Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy NuVasive stock
Learn how to easily invest in NuVasive stock.
NuVasive Inc is a medical devices business based in the US. NuVasive shares (NUVA) are listed on the NASDAQ and all prices are listed in US Dollars. NuVasive employs 2,900 staff and has a trailing 12-month revenue of around $1.2 billion.
How to buy shares in NuVasive
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NUVA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NuVasive stock price (NASDAQ: NUVA)Use our graph to track the performance of NUVA stocks over time.
NuVasive shares at a glance
|Latest market close||$43.96|
|52-week range||$41.33 - $62.83|
|50-day moving average||$48.10|
|200-day moving average||$51.64|
|Wall St. target price||$59.92|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.72|
Buy NuVasive shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NuVasive stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NuVasive price performance over time
|1 week (2022-09-28)||-1.08%|
|1 month (2022-09-02)||1.41%|
|3 months (2022-07-05)||-12.71%|
|6 months (2022-04-05)||-19.78%|
|1 year (2021-10-05)||-26.71%|
|2 years (2020-10-05)||-9.58%|
|3 years (2019-10-04)||64.52|
|5 years (2017-10-05)||56.46|
Is NuVasive stock undervalued or overvalued?
Valuing NuVasive stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NuVasive's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NuVasive's PEG ratio
NuVasive's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7855. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NuVasive's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NuVasive's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $193.6 million.
The EBITDA is a measure of a NuVasive's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.2 billion|
|Operating margin TTM||4.85%|
|Gross profit TTM||$816.7 million|
|Return on assets TTM||1.65%|
|Return on equity TTM||-4.81%|
|Market capitalisation||$2.3 billion|
TTM: trailing 12 months
NuVasive share dividends
We're not expecting NuVasive to pay a dividend over the next 12 months.
NuVasive share price volatility
Over the last 12 months, NuVasive's shares have ranged in value from as little as $41.33 up to $62.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuVasive's is 1.1786. This would suggest that NuVasive's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NuVasive, Inc. , a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc.
NuVasive in the news
NuVasive Announces Agenda for Investor Day 2022
NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio
NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '22
Frequently asked questionsWhat percentage of NuVasive is owned by insiders or institutions?
Currently 0.228% of NuVasive shares are held by insiders and 106.702% by institutions. How many people work for NuVasive?
Latest data suggests 2,900 work at NuVasive. When does the fiscal year end for NuVasive?
NuVasive's fiscal year ends in December. Where is NuVasive based?
NuVasive's address is: 7475 Lusk Boulevard, San Diego, CA, United States, 92121 What is NuVasive's ISIN number?
NuVasive's international securities identification number is: US6707041058 What is NuVasive's CUSIP number?
NuVasive's Committee on Uniform Securities Identification Procedures number is: 670704105
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert